GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Similar documents
Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Prakash Industries BUY. Performance Highlights. CMP Target Price `81 `124. 3QFY2011 Result Update Steel

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

Mahindra & Mahindra Ltd.

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Amber Enterprises India Ltd

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Century Plyboards Ltd

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

SUN TV Network NEUTRAL. Performance Highlights CMP. `297 Target Price - 1QFY2013 Result Update Media. Investment Period -

Hindalco NEUTRAL. Performance highlights CMP. `112 Target Price - 1QFY2013 Result Update Base Metals. Investment Period -

Mahindra & Mahindra Ltd.

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Hero MotoCorp NEUTRAL. Performance Highlights. CMP `2,245 Target Price - 4QFY2012 Result Update Automobile. Investment Period - Key financials

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

BGR Energy Systems NEUTRAL. Performance Highlights CMP. `235 Target Price - 3QFY2013 Result Update Capital Goods. Investment Period -

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Simplex Infrastructures

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Mahindra & Mahindra Ltd.

Sesa Goa NEUTRAL. Performance Highlights CMP. `372 Target Price - 2QFY2011 Result Update Mining. Investment Period -

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Hindustan Media Ventures

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

JK Lakshmi Cement BUY. Performance Highlights CMP. `63 Target Price `79. 4QFY2012 Result Update Cement. Investment Period 12 Months

HT Media ACCUMULATE. Performance Highlights CMP. `102 Target Price `113. 3QFY2013 Result Update Media. Investment Period 12 months

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Apollo Tyres BUY. Performance Highlights. CMP Target Price `71 `82. 4QFY2011Result Update Tyre. Key financials (Consolidated)

Procter & Gamble Hygiene & Health Care

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

BGR Energy Systems ACCUMULATE. Performance Highlights CMP. `482 Target Price `520. 4QFY2011 Result Update Capital Goods. Investment Period 12 Months

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Cadila Healthcare ACCUMULATE. Performance Highlights. CMP 860 Target Price QFY2013 Result Update Pharmaceutical. Key financials (Consolidated)

MRF BUY. Performance Highlights. CMP `40,703 Target Price `47,548. 1QSY2015 Result Update Tyre

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

SUN TV Network NEUTRAL. Performance Highlights CMP. `369 Target Price - 2QFY2013 Result Update Media. Investment Period -

Simplex Infrastructures

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

SpiceJet ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I Aviation

Thermax NEUTRAL. Performance Highlights CMP. `673 Target Price - 3QFY2011 Results Update Capital Goods. Investment Period -

Reliance Communication

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

Tech Mahindra ACCUMULATE. Performance Highlights. CMP Target Price `659 `693. 3QFY2012 Result Update IT. Key financials (Consolidated, Indian GAAP)

ITD Cementation India

Cipla BUY. Performance Highlights CMP. `310 Target Price `369. 2QFY2012 Result Update Pharmaceutical. Investment Period 12 months

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Apollo Tyres BUY. Performance Highlights. CMP Target Price `56 `65. 3QFY2011Result Update Tyre. Key Financials (Consolidated)

Advisory Desk. TVS Srichakra Ltd. BUY CMP. `355 Target Price `468. Investment rationale. Outlook and valuation. Investment Period 12 Months

Mahindra & Mahindra BUY. CMP Target Price `860 `990. Company Update Automobile

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Container Corporation of India

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Sun Pharma NEUTRAL. Performance Highlights CMP. 1QFY2013 Result Update Pharmaceutical. `676 Target Price - Investment Period -

Tech Mahindra ACCUMULATE. Performance Highlights CMP. `955 Target Price `1,070. 2QFY2013 Result Update IT. Investment Period 12 months

Lupin NEUTRAL. Performance Highlights CMP. `448 Target Price - 2QFY2011 Result Update Pharmaceutical. Investment Period -

Nestle India NEUTRAL. Performance Highlights. CMP `4,387 Target Price - 2QCY2012 Result Update FMCG. Quarterly results. Investment Period -

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

Aurobindo Pharma BUY. Performance Highlights CMP. `109 Target Price `156. 1QFY2013 Result Update Pharmaceutical. Investment Period 12 months

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

Dr. Reddy s Laboratories

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Colgate-Palmolive ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I FMCG

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Transcription:

2QFY2013 Result Update Oil & Gas October 26, 2012 GAIL India Performance Highlights Quarterly highlights (Standalone) Y/E March (` cr) 2QFY2013 2QFY2012 % chg (yoy) 1QFY2013 % chg (qoq) Net sales 11,361 9,699 17.1 11,089 2.5 EBITDA 1,380 1,676 (17.6) 1,899 (27.3) EBITDA margin (%) 12.1 17.3 (513)bp 17.1 (498)bp Adj. PAT 985 1,094 (10.0) 1,134 (13.1) For 2QFY2013, GAIL India (GAIL) reported a lower-than-expected profit due to lower-than-expected profit from natural gas trading and LPG segments. We maintain our Neutral rating on the stock. Top-line grew by 17.1% yoy: GAIL s top-line grew by 17.1% yoy to `11,361cr below our estimate of `12,196cr, mainly due to weak performance in the natural gas trading segment and the LPG segment. The revenues from the natural gas trading business grew by 28.0% yoy to `9,697cr. However, gas transmission volumes decreased by 10.9% yoy to 106mmscmd during 2QFY2013. The company s share of fuel subsidy burden increased by 38.6% yoy to `786cr in 2QFY2013. EBITDA declines by 17.6% yoy: The EBIT of the natural gas trading and LPG segments decreased by 14.6% and 81.1% yoy to `245cr and `66cr, respectively. Consequently, GAIL s EBITDA decreased by 17.6% yoy to `1,380cr; the EBITDA margin also contracted by 513bp yoy to 12.1% in 2QFY2013. Higher other income mutes bottom-line decline: Other income increased by 104.1% yoy to `237cr whereas the interest costs increased by 15.5% yoy to `26cr. Consequently, the net profit decreased by 10.0% yoy to `985cr, much below of our estimate of `1,129cr. Outlook and valuation: Over the past one year, gas production from the KG basin has declined significantly. Further, we do not expect any meaningful increase in the production at KG D6 over the coming two years. Hence, we expect utilization levels for GAIL s pipelines to remain low during FY2013-14. Moreover, a cap on the gas marketing margin (which is currently under review by the Petroleum and Natural Gas Regulatory Board [PNGRB]) would remain an overhang on the stock. Hence, we maintain our Neutral rating on the stock. NEUTRAL CMP `363 Target Price - Investment Period - Stock Info Sector Oil & Gas Market Cap (` cr) Net debt (` cr) 46,103 0.7 Beta 52 Week High / Low Avg. Daily Volume 3,958 432/303 69,628 Face Value (`) BSE Sensex Nifty Reuters Code Bloomberg Code 10 18,625 5,664 GAIL.BO GAIL@IN Shareholding Pattern (%) Promoters 57.3 MF / Banks / Indian Fls 16.5 FII / NRIs / OCBs 15.2 Indian Public / Others 11.0 Abs. (%) 3m 1yr 3yr Sensex 11.9 7.7 11.3 GAIL 5.7 (15.2) 1.6 Key financials - Standalone Y/E March (` cr) FY2011 FY2012 FY2013E FY2014E Net sales 32,459 40,398 46,652 54,142 % chg 29.9 24.5 15.5 16.1 Net profit 3,561 3,654 4,314 4,472 % chg 13.4 2.6 18.1 3.7 OPM (%) 16.8 14.4 15.7 15.7 EPS (`) 28.1 28.8 34.0 35.3 P/E (x) 12.9 12.6 10.7 10.3 P/BV (x) 2.4 2.1 1.8 1.6 RoE (%) 19.7 17.9 18.5 16.8 RoCE (%) 22.4 19.3 19.8 18.1 EV/Sales (x) 1.3 1.1 0.9 0.7 EV/EBITDA (x) 7.9 8.0 5.8 4.7 Bhavesh Chauhan Tel: 022-3935 7800 Ext: 6821 bhaveshu.chauhan@angelbroking.com Vinay Rachh Tel: 022-39357600 Ext: 6841 vinay.rachh@angelbroking.com Please refer to important disclosures at the end of this report 1

Exhibit 1: 2QFY2013 performance (Standalone) Y/E March (` cr) 2QFY2013 2QFY2012 % (yoy) 1QFY2013 % (qoq) 1HFY2013 1HFY2012 % (yoy) Net sales 11,361 9,699 17.1 11,089 2.5 22,450 18,566 20.9 COGS 9,163 7,224 26.8 8,085 13.3 17,248 14,014 23.1 Total operating expenditure 9,981 8,023 24.4 9,190 8.6 19,170 15,314 25.2 EBITDA 1,380 1,676 (17.6) 1,899 (27.3) 3,279 3,253 0.8 EBITDA margin (%) 12.1 17.3 17.1 14.6 17.5 Other income 237 116 104.1 38 526.4 275 181 52.0 Depreciation 249 201 24.1 217 14.8 466 379 23.0 Interest 26 23 15.5 59 (55.6) 85 43 95.6 PBT 1,374 1,568 (12.4) 1,685 (18.5) 3,058 3,011 1.6 PBT margin (%) 12.1 16.2 15.2 13.6 16.2 Total tax 388 474 (18.1) 551 (29.5) 939 932 0.8 % of PBT 28.3 30.2 32.7 30.7 31.0 PAT 985 1,094 (10.0) 1,134 (13.1) 2,119 2,079 1.9 Exceptional items - - Adj. PAT 985 1,094 (10.0) 1,134 (13.1) 2,119 2,079 1.9 PAT margin (%) 8.7 11.3 10.2 9.4 11.2 October 26, 2012 2

Exhibit 2: Segmental performance (Standalone) Y/E March (` cr) 2QFY2013 2QFY2012 % (yoy) 1QFY2013 % (qoq) 1HFY2013 1HFY2012 % (yoy) NG trading 9,697 7,575 28.0 9,242 4.9 18,939 14,781 28.1 Petrochemical 880 938 (6.2) 574 53.2 1,454 1,575 (7.7) LPG & liquid hydrocarbons 769 989 (22.2) 1072 (28.2) 1842 1803 2.2 Transmission NG 985 980 0.5 915 7.6 1900 1919 (1.0) Transmission LPG (4) 110 (103.6) 114 (103.4) 110 224 (51.0) Gailtel - - - - - Others 76 26 194.7 56 35.3 132 48 176.5 Total 12,403 10,617 16.8 11,973 3.6 24,376 20,349 19.8 Less: Inter segmental 1041 918 13.4 885 17.7 1926 1782 8.1 Sales 11,361 9,699 17.1 11,089 2.5 22,450 18,566 20.9 EBIT NG trading 245 287 (14.6) 496 (50.6) 740 600 23.5 %EBIT 39.6 26.4 18.6 25.6 24.6 Petrochemical 418 404 3.5 196 113.6 614 647 (5.2) %EBIT 47.5 43.1 34.1 42.2 LPG & Liquid hydrocarbons 66 352 (81.1) 437 (84.8) 504 581 (13.2) %EBIT 8.6 35.6 40.8 27.4 Transmission NG 605 556 8.7 567 6.6 1,172 1,208 (3.0) % EBIT 61.4 56.8 62.0 61.7 Transmission LPG (49) 72 (167.7) 71 (169.0) 22 141 (84.4) % EBIT 1254.4 65.8 62.4 20.1 Gailtel - - - - - % EBIT - - - - - Others 7 (82) (108) 8 (14.2) 15 (115) (113) % EBIT - - - Total EBIT 1,292 1,589 (18.7) 1,775 (27.2) 3,067 3,062 0.2 % EBIT 11.4 16.4 16.0 13.7 Less: Interest 26 23 15.5 59 (55.6) 85 43 95.6 Less: Unallocable exp 108 (1) - (32) - 76 7 - Profit before tax 1,374 1,568 (12.4) 1,685 (18.5) 3,058 3,011 1.6 Exhibit 3: 2QFY2013 Actual vs Angel estimates (` cr) Actual Estimates Variation (%) Net sales 11,361 12,196 (6.8) EBITDA 1,380 1,915 (27.9) EBITDA margin (%) 12.1 15.7 (355)bp Adj. PAT 985 1,129 (12.7) October 26, 2012 3

Top-line grew by 17.1% yoy: GAIL s top-line grew by 17.1% yoy to `11,361cr below our estimate of `12,196cr, mainly due to weak performance in the natural gas trading segment and LPG segment. The revenues from the natural gas trading business grew by 28.0% yoy to `9,697cr. However, gas transmission volumes decreased by 10.9% yoy to 106mmscmd during 2QFY2013. The company s share of fuel subsidy burden increased by 38.6% yoy to `786cr in 2QFY2013. Exhibit 4: Net sales grew by 17.1% yoy (` cr) 12,000 10,000 8,000 6,000 36.4 8,894 8,867 25.0 9,699 19.7 11,260 34.6 10,455 11,089 11,361 25.0 40.0 35.0 30.0 25.0 20.0 (%) 4,000 2,000 17.6 17.1 15.0 10.0 5.0-4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 Net Sales Net Sales growth (RHS) - Exhibit 5: GAIL s subsidy share stood at `786cr Exhibit 6: Transmission volumes continue to decline (` cr) 1,600 1,400 1,200 1,000 800 600 400 200 0 340 450 350 420 900 680 567 536 1,397 700 786 (mmscmd) 125 120 115 110 105 100 95 115 116 115 120 120 117 119 119 116 110 106 4QFY10 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 4QFY10 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 GAIL's subsidy share NG Transmission volumes EBITDA declines by 17.6% yoy: The EBIT of the natural gas trading and LPG segments decreased by 14.6% and 81.1% yoy to `245cr and `66cr, respectively. Consequently, GAIL s EBITDA decreased by 17.6% yoy to `1,380cr; the EBITDA margin also contracted by 513bp yoy to 12.1% in 2QFY2013. October 26, 2012 4

Exhibit 7: EBITDA stood at `1,380cr (` cr) 2,000 1,800 1,600 1,400 1,200 1,000 800 600 400 200-17.8 17.3 1,899 17.1 14.3 15.6 1,380 12.1 1,577 1,676 1,761 1,272 734 7.0 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 EBITDA EBITDA margins (RHS) 19.0 17.0 15.0 13.0 11.0 9.0 7.0 5.0 (%) Higher other income mutes bottom-line decline: Other income increased by 104.1% yoy to `237cr whereas the interest costs increased by 15.5% yoy to `26cr. Consequently, the net profit decreased by 10.0% yoy to `985cr, below our estimate of `1,129cr. Exhibit 8: Adjusted PAT declined by 10.0% yoy (` cr) 1,200 1,000 800 600 400 200-1,134 30.6 985 11.0 12.8 15.1 (14.0) 1,094 (10.0) 985 783 1,091 (38.3) 483 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 Adj. PAT Adj. PAT growth (RHS) 40.0 30.0 20.0 10.0 - (10.0) (20.0) (30.0) (40.0) (50.0) (%) October 26, 2012 5

Investment arguments Upstream segment could see triggers: GAIL s asset portfolio includes prospective basins such as Myanmar fields and CBM blocks. We view these blocks as a potential upside for the stock. Of the 27 exploratory blocks owned by GAIL, nine blocks have potential hydrocarbon discoveries. Any material success in the form of a major discovery could be a key catalyst for the stock. Falling domestic gas production remains a concern: GAIL is expanding its transmission capacity from 170mmscmd currently to 300mmscnd in the next two years. However, gas production from the KG basin has declined significantly over the past one year. Looking ahead, we do not expect any meaningful increase in production in the production at KG D6 in the coming two years. Hence, we expect utilization levels for GAIL s pipelines to remain low during FY2013-14. Outlook and valuation Over the past one year, gas production from the KG basin has declined significantly. Further, we do not expect any meaningful increase in KG D6 production over the coming two years. Hence, we expect utilization levels for GAIL s pipelines to remain low during FY2013-14. Further, a cap on gas marketing margin (which is currently under review by PNGRB) would remain an overhang on the stock. Hence, we maintain our Neutral rating on the stock. Exhibit 9: SOTP valuation (FY2014E) Business segment (` cr) EV `/share NG transmission (EV/EBITDA 4.0x) 16,111 127 LPG transmission (EV/EBITDA 4.0x) 1,469 12 NG trading (EV/EBITDA 4.0x) 2,527 20 Petrochemicals (EV/EBITDA 4.0x) 9,021 71 LPG and liquid hydrocarbons (EV/EBITDA 4.0x) 6,419 51 E&P upsides (EV/boe 4.0x) 1,829 14 Investments (Book/Market Value X 80%) 4,478 35 Total EV 41,854 330 Net debt (2,743) (22) Equity value (`) 44,597 352 October 26, 2012 6

Exhibit 10: Key assumptions Particulars FY2013E FY2014E Gas transmission volumes (mmscmd) 110 115 Gas trading volumes (mmscmd) 84 89 Exhibit 11: Angel EPS forecast vs consensus (`) Angel forecast Bloomberg consensus Variation (%) FY2013E 34.0 34.4 (1.1) FY2014E 35.3 36.8 (4.2) Exhibit 12: One-year forward P/E Share price (`) 800 700 600 500 400 300 200 100 0 Nov-06 Apr-07 Sep-07 Feb-08 Jul-08 Dec-08 May-09 Oct-09 Mar-10 Aug-10 Jan-11 Jun-11 Nov-11 Apr-12 Sep-12 7x 10x 13x 16x 19x Exhibit 13: Recommendation summary Company CMP TP Reco. Mcap Upside P/E (x) P/BV (x) EV/EBITDA (x) RoE (%) RoCE (%) (`) (`) (` cr) (%) FY13E FY14E FY13E FY14E FY13E FY14E FY13E FY14E FY13E FY14E RIL 799 - Neutral 263,048-13.3 12.6 1.3 1.2 8.4 7.6 11.0 10.6 7.4 7.7 ONGC 275 312 Accum. 235,361 13 9.1 8.7 1.6 1.4 4.0 3.7 18.3 17.2 19.3 18.4 Cairn India 335 382 Accum. 64,047 14 5.5 5.9 1.1 1.0 3.7 3.3 22.0 17.5 21.4 17.1 GAIL 363 - Neutral 46,103-10.7 10.3 1.8 1.6 5.8 4.7 18.5 16.8 19.8 18.1 Source: Angel Research Company background Incorporated in August 1984, GAIL is India's flagship transmission and distribution natural gas company engaged in the businesses of natural gas, LPG, liquid hydrocarbons and petrochemicals. The company s segments include natural gas marketing, natural gas transmission, liquefied petroleum gas (LPG) transmission projects and other hydrocarbon production. Currently, GAIL operates a natural gas transmission network of ~8,000km, with a capacity of 170mmscmd. The company also has 27 oil and gas exploration blocks and three coal bed methane blocks. The company has also diversified into exploration and production and city gas distribution (CGD). October 26, 2012 7

Profit and Loss Statement (Standalone) Y/E March (` cr) FY09 FY10 FY11 FY12 FY13E FY14E Gross sales 24,292 25,376 32,953 40,843 47,363 54,967 Less: Excise duty 516 379 494 562 710 824 Net Sales 23,776 24,996 32,459 40,281 46,652 54,142 Other operating income - - - 117 - Total operating income 23,776 24,996 32,459 40,398 46,652 54,142 % chg 32.0 5.1 29.9 24.5 15.5 16.1 Total Expenditure 19,711 20,327 27,004 34,583 39,349 45,637 Net Raw Materials 16,452 17,609 22,006 30,437 34,631 39,404 Other Mfg costs 870 950 2,046 1,168 1,444 1,786 Personnel 577 621 753 607 691 786 Other 1,813 1,147 2,199 2,371 2,837 3,394 EBITDA 4,065 4,669 5,455 5,815 7,304 8,505 % chg 3.5 14.9 16.8 6.6 25.6 16.4 (% of Net Sales) 17.1 18.7 16.8 14.4 15.7 15.7 Depreciation & Amortization 560 562 650 791 996 1,840 EBIT 3,505 4,107 4,804 5,025 6,308 6,665 % chg 4.4 17.2 17.0 4.6 25.5 5.7 (% of Net Sales) 14.7 16.4 14.8 12.4 13.5 12.3 Interest & other Charges 87 70 83 116 206 226 Other Income 797 541 519 432 359 215 (% of PBT) 18.9 11.8 9.9 8.1 5.6 3.2 Share in profit of Associates - - - - - - Recurring PBT 4,214 4,578 5,240 5,340 6,461 6,654 % chg 9.9 8.6 14.4 1.9 21.0 3.0 Extraordinary Expense/(Inc.) - - - - - - PBT (reported) 4,214 4,578 5,240 5,340 6,461 6,654 Tax 1,400 1,439 1,679 1,686 2,147 2,183 (% of PBT) 33.2 31.4 32.0 31.6 33.2 32.8 PAT (reported) 2,814 3,140 3,561 3,654 4,314 4,472 Add: Share of earnings of asso. - - - - - - Less: Minority interest (MI) - - - - - - Prior period items 10 - - - - - PAT after MI (reported) 2,804 3,140 3,561 3,654 4,314 4,472 ADJ. PAT 2,804 3,140 3,561 3,654 4,314 4,472 % chg 7.8 12.0 13.4 2.6 18.1 3.7 (% of Net Sales) 11.8 12.6 11.0 9.0 9.2 8.3 Basic EPS (`) 22.1 24.8 28.1 28.8 34.0 35.3 Fully Diluted EPS (`) 22.1 24.8 28.1 28.8 34.0 35.3 % chg 7.8 12.0 13.4 2.6 18.1 3.7 October 26, 2012 8

Balance Sheet (Standalone) Y/E March (` cr) FY09 FY10 FY11 FY12 FY13E FY14E SOURCES OF FUNDS Equity Share Capital 1,268 1,268 1,268 1,268 1,268 1,268 Reserves& Surplus 13,501 15,655 17,985 20,356 23,655 27,112 Shareholders Funds 14,770 16,924 19,253 21,624 24,923 28,380 Minority Interest - - - - - - Total Loans 1,200 1,480 1,973 4,889 7,389 8,389 Deferred Tax Liability 1,326 1,390 1,633 1,769 1,769 1,769 Other Long Term Liabilities - - 15 278 278 278 Long Term Provisions - - 289 338 338 338 Total Liabilities 17,296 19,794 23,164 28,898 34,697 39,153 APPLICATION OF FUNDS Gross Block 17,604 17,904 22,144 26,307 28,807 33,307 Less: Acc. Depreciation 8,554 9,115 9,741 10,449 11,445 13,284 Net Block 9,050 8,789 12,404 15,858 17,362 20,022 Capital Work-in-Progress 2,426 5,426 5,846 7,942 8,530 7,330 Goodwill - - - - - - Investments 1,737 2,073 2,583 3,549 3,549 3,549 Long Term Loans and advances - - 1,687 1,996 1,996 1,996 Other non-current assets - - 73 272 272 272 Current Assets 12,237 13,884 9,420 9,468 15,996 20,423 Cash 3,456 4,343 2,131 931 7,270 11,132 Loans & Advances 6,621 7,606 4,596 5,211 5,211 5,211 Other 2,159 1,935 2,692 3,325 3,515 4,079 Current liabilities 8,155 10,378 8,848 10,186 13,008 14,438 Net Current Assets 4,082 3,506 572 (719) 2,988 5,985 Mis. Exp. not written off - - - - - - Total Assets 17,296 19,794 23,164 28,898 34,697 39,153 October 26, 2012 9

Cash Flow (Standalone) Y/E March (` cr) FY09 FY10 FY11 FY12 FY13E FY14E Profit before tax 4,204 4,578 5,240 5,340 6,461 6,654 Depreciation 560 562 650 792 996 1,840 Change in Working Capital (749) 1,453 722 91 2,632 866 Others (797) (541) (2,051) (310) (359) (215) Less: Other income - - - - - - Direct taxes paid (1,394) (1,375) (1,484) (1,425) (2,147) (2,183) Cash Flow from Operations 1,824 4,677 3,077 4,488 7,583 6,962 (Inc.)/ Dec. in Fixed Assets (2,256) (3,300) (4,632) (6,618) (3,088) (3,300) (Inc.)/ Dec. in Investments (246) (336) (509) (965) - - Others 797 220 412 442 - - Other income - - - - 359 215 Cash Flow from Investing (1,706) (3,416) (4,729) (7,142) (2,729) (3,085) Issue of Equity - - - - - - Inc./(Dec.) in loans (66) 280 830 3,037 2,500 1,000 Dividend Paid (Incl. Tax) (1,039) (1,113) (1,109) (1,253) (1,015) (1,015) Others (31) 287 (108) (330) - - Cash Flow from Financing (1,136) (546) (388) 1,454 1,485 (15) Inc./(Dec.) in Cash (1,017) 715 (2,040) (1,200) 6,339 3,862 Opening Cash balances 4,473 3,456 4,172 2,131 931 7,270 Closing Cash balances 3,456 4,172 2,131 931 7,270 11,132 October 26, 2012 10

Key Ratios Y/E March FY09 FY10 FY11 FY12 FY13E FY14E Valuation Ratio (x) P/E (on FDEPS) 16.4 14.7 12.9 12.6 10.7 10.3 P/CEPS 13.7 12.4 10.9 10.4 8.7 7.3 P/BV 3.1 2.7 2.4 2.1 1.8 1.6 Dividend yield (%) 1.9 2.1 2.1 2.7 2.2 2.2 EV/Sales 1.8 1.6 1.3 1.1 0.9 0.7 EV/EBITDA 10.3 8.8 7.9 8.0 5.8 4.7 EV/Total Assets 2.4 2.1 1.9 1.6 1.2 1.0 Per Share Data (`) EPS (Basic) 22.1 24.8 28.1 28.8 34.0 35.3 EPS (fully diluted) 22.1 24.8 28.1 28.8 34.0 35.3 Cash EPS 26.5 29.2 33.2 35.0 41.9 49.8 DPS 7.0 7.5 7.5 9.9 8.0 8.0 Book Value 116.4 133.4 151.8 170.5 196.5 223.7 DuPont Analysis (%) EBIT margin 14.7 16.4 14.8 12.4 13.5 12.3 Tax retention ratio 66.8 68.6 68.0 68.4 66.8 67.2 Asset turnover (x) 1.9 1.7 1.8 1.6 1.7 2.0 ROIC (Post-tax) 18.8 19.2 17.9 14.0 15.2 16.2 Cost of Debt (Post Tax) - - - - - - Leverage (x) - - - - - - Operating ROE 18.8 19.2 17.9 14.0 15.2 16.2 Returns (%) ROCE (Pre-tax) 21.3 22.1 22.4 19.3 19.8 18.1 Angel ROIC (Pre-tax) 32.3 38.3 38.1 28.5 32.4 33.7 ROE 20.2 19.8 19.7 17.9 18.5 16.8 Turnover ratios (x) Asset Turnover (Gross Block) 1.4 1.4 1.6 1.7 1.7 1.7 Inventory / Sales (days) 9.0 9.0 8.4 8.3 8.3 8.3 Receivables (days) 20 20 18 18 17 17 Payables (days) 70 86 69 67 78 77 WC cycle (ex-cash) (days) 4 (2) (13) (14) (23) (32) Solvency ratios (x) Net debt to equity (0.3) (0.3) (0.1) 0.0 (0.1) (0.2) Net debt to EBITDA (1.0) (1.1) (0.5) 0.1 (0.5) (0.7) Interest Coverage (EBIT/Int.) 40.3 58.7 58.0 43.1 30.7 29.4 October 26, 2012 11

Research Team Tel: 022 3935 7800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may have investment positions in the stocks recommended in this report. Disclosure of Interest Statement GAIL 1. Analyst ownership of the stock No 2. Angel and its Group companies ownership of the stock No 3. Angel and its Group companies' Directors ownership of the stock No 4. Broking relationship with company covered No Note: We have not considered any Exposure below ` 1 lakh for Angel, its Group companies and Directors. Ratings (Returns) : Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) Reduce (-5% to 15%) Sell (< -15%) October 26, 2012 12